Gut Microbiota and Their Metabolites: The Hidden Driver of Diabetic Nephropathy? Unveiling Gut Microbe's Role in DN

ABSTRACT Background Diabetic nephropathy (DN) is a severe microvascular complication of diabetes with a complex pathogenesis. Methods Recent studies were reviewed to explore the role of gut microbiota and its metabolites in DN development. Results Dysbiosis of gut bacteria contributes to pathologica...

Full description

Bibliographic Details
Published in:	Journal of Diabetes
Main Authors:	Jinzhou Liu, Min Guo, Xiaobin Yuan, Xiao Fan, Jin Wang, Xiangying Jiao
Format:	Article
Language:	English
Published:	Wiley 2025-04-01
Subjects:	diabetic nephropathy gut microbiota gut–kidney axis microbial metabolites novel biomarkers
Online Access:	https://doi.org/10.1111/1753-0407.70068

Similar Items

The roles of gut microbiota and its metabolites in diabetic nephropathy
by: Hui Zhao, et al.
Published: (2023-07-01)

Exploring the beneficial effect of gut microbiota metabolites on diabetic nephropathy via network pharmacology study
by: Weiguo Yao, et al.
Published: (2025-04-01)

Microbiota-derived metabolites as drivers of gut–brain communication
by: Hany Ahmed, et al.
Published: (2022-12-01)

The pathogenic role of intestinal flora metabolites in diabetic nephropathy
by: En Tian, et al.
Published: (2023-07-01)

Gut microbial metabolites and the brain–gut axis in Alzheimer’s disease: A review
by: Xinchen Ji, et al.
Published: (2025-08-01)

Inflammatory Bowel Diseases and Nephropathies: Exploring the Gut–Kidney Axis
by: Roberto de Sire, et al.
Published: (2024-11-01)

Gut microbiota microbial metabolites in diabetic nephropathy patients: far to go
by: Jian-Xiu Yu, et al.
Published: (2024-05-01)

Severity of atopic dermatitis is associated with gut-derived metabolites and leaky gut-related biomarkers
by: Leszek Blicharz, et al.
Published: (2025-07-01)

The dysbiosis of gut microbiota and dysregulation of metabolites in IgA nephropathy and membranous nephropathy
by: Lei Zhang, et al.
Published: (2025-07-01)

The gut microbiota and diabetic nephropathy: an observational study review and bidirectional Mendelian randomization study
by: Yi Zhen Han, et al.
Published: (2025-03-01)

Gut microbiota metabolites: potential therapeutic targets for Alzheimer’s disease?
by: Shanshan Zhang, et al.
Published: (2024-09-01)

Deciphering the causal link between gut microbiota and membranous nephropathy: insights into potential inflammatory mechanisms
by: Jianbo Qing, et al.
Published: (2025-12-01)

Research Progress in Microbe-Gut-Liver Axis and Alcoholic Liver Disease and Nutritional Interventions for It
by: ZHENG Hongxing, JI Le, QI Shanshan
Published: (2024-10-01)

Gut microbiota’s role in glioblastoma risk, with a focus on the mediating role of metabolites
by: Junqing Yan, et al.
Published: (2024-07-01)

The role of the gut microbiome and its metabolites in cerebrovascular diseases
by: Hongyu Xu, et al.
Published: (2023-04-01)

The gut-derived metabolites as mediators of the effect of healthy nutrition on the brain
by: Quentin Leyrolle, et al.
Published: (2023-06-01)

Gut microbes and food reward: From the gut to the brain
by: Alice de Wouters d’Oplinter, et al.
Published: (2022-07-01)

The Inflammatory Mechanism of Parkinson’s Disease: Gut Microbiota Metabolites Affect the Development of the Disease Through the Gut–Brain Axis
by: Ai Gao, et al.
Published: (2025-02-01)

Modulation of the Neuro–Cancer Connection by Metabolites of Gut Microbiota
by: Alice N. Mafe, et al.
Published: (2025-02-01)

Gut Microbiota Influences Meningioma Pathogenesis via Circulating Metabolites: A Two‐Sample Mendelian Randomization Study
by: Xuan Chen, et al.
Published: (2025-10-01)

Depression-associated gut microbes, metabolites and clinical trials
by: Meiling Wang, et al.
Published: (2024-01-01)

Food and Gut Microbiota-Derived Metabolites in Nonalcoholic Fatty Liver Disease
by: Min Kyo Jeong, et al.
Published: (2022-09-01)

Investigating causal associations among gut microbiota, metabolites and autoimmune hypothyroidism: a univariable and multivariable Mendelian randomization study
by: Xue Liu, et al.
Published: (2024-01-01)

Elucidating the causal relationship between gut microbiota, metabolites, and diabetic nephropathy in European patients: Revelations from genome-wide bidirectional mendelian randomization analysis
by: Siyuan Song, et al.
Published: (2025-01-01)

Research progress of diabetic retinopathy and gut microecology
by: Rui Wang, et al.
Published: (2023-09-01)

Editorial: Food-derived phytochemicals as regulators of gut microbiota
by: Samanta Thomas-Valdés, et al.
Published: (2025-08-01)

Dissecting causal relationships between gut microbiota, blood metabolites, and glioblastoma multiforme: a two-sample Mendelian randomization study
by: Xuan Chen, et al.
Published: (2024-07-01)

Gut bacteria: an etiological agent in human pathological conditions
by: Md Minarul Islam, et al.
Published: (2024-10-01)

Gut Microbiota to Microglia: Microbiome Influences Neurodevelopment in the CNS
by: Jeffery Bettag, et al.
Published: (2023-10-01)

Vaccinium myrtillus L. ameliorates diabetic nephropathy via modulating metabolites and gut microbiota in rats
by: Xinxin Cao, et al.
Published: (2025-04-01)

Research progress of gut microbiome and diabetic nephropathy
by: Chenling Chu, et al.
Published: (2024-12-01)

Dual regulatory effects of gut microbiota and their metabolites in rheumatoid arthritis: balancing pathogenic and protective mechanisms
by: Xingwen Xie, et al.
Published: (2025-04-01)

Gut Microbiota and Respiratory Infections: Insights from Mendelian Randomization
by: Shengyu Huang, et al.
Published: (2023-08-01)

Gut–Liver–Pancreas Axis Crosstalk in Health and Disease: From the Role of Microbial Metabolites to Innovative Microbiota Manipulating Strategies
by: Giada Marroncini, et al.
Published: (2024-06-01)

Role of gut microbiota and its metabolites in diabetic cardiomyopathy: from pathogenesis to interventions
by: Zheng Ji, et al.
Published: (2025-09-01)

Effect of gut microbiome-derived metabolites and extracellular vesicles on hepatocyte functions in a gut-liver axis chip
by: Seong Goo Kang, et al.
Published: (2023-01-01)

Research progress in the role of gut microbiota in the pathogenesis and treatment of IgA nephropathy
by: LI Junru, et al.
Published: (2023-08-01)

Parkinson's disease: Are gut microbes involved?
by: Abass Olawale Omotosho, et al.
Published: (2023-08-01)

The Influence of Gut Dysbiosis in the Pathogenesis and Management of Ischemic Stroke
by: Saravana Babu Chidambaram, et al.
Published: (2022-04-01)

The role of the tryptophan metabolites in gut microbiota-brain axis and potential treatments: a focus on ischemic stroke
by: Na Qin, et al.
Published: (2025-06-01)